Illinois Joins WHO Global Outbreak Network After U.S. Exit, Following California’s Lead 
Marco Rubio Steps Down as Acting U.S. Archivist Amid Federal Law Limits 
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales 
Trump Threatens 50% Tariff on Canadian Aircraft Amid Escalating U.S.-Canada Trade Dispute 
Ukraine-Russia Talks Yield Major POW Swap as U.S. Pushes for Path to Peace 
Federal Judge Restores Funding for Gateway Rail Tunnel Project 
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit 
New York Legalizes Medical Aid in Dying for Terminally Ill Patients 
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race 
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
The U.S. Department of Health and Human Services (HHS) is evaluating the Centers for Disease Control and Prevention’s (CDC) HIV Prevention Division for potential overlap with other agencies, though no final decision has been made. Reports from The Wall Street Journal and NBC suggest the division, which has a $1.3 billion budget dedicated to tracking HIV infections, promoting testing, and supporting prevention efforts like PrEP, may be dismantled.
Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, stated that funding for the division is uncertain, with a final decision expected soon. Schmid, who co-chaired the Presidential Advisory Council on HIV/AIDS under former President Donald Trump, noted that all division funding remains "up in the air."
HHS clarified that any potential restructuring aligns with broader government efficiency efforts and assured that HIV prevention work would continue under other agencies if changes occur. The Ryan White HIV/AIDS Program, under the Health Resources and Services Administration, currently provides HIV health services for low-income individuals.
Concerns over cuts to HIV prevention have sparked advocacy efforts from groups like AIDS United, urging the public to contact elected officials. CEO Jesse Milan emphasized the division’s role in protecting 1.2 million people at risk of HIV infection, separate from those already living with the virus. Activists fear moving services to a different agency may significantly reduce prevention efforts.
This review follows the Trump administration’s earlier decision to halt U.S.-funded HIV medication distribution in foreign clinics, disrupting treatment for millions. The potential restructuring raises concerns over the future of domestic HIV prevention efforts amid growing public health challenges.
